| Tag | Content |
|---|
EnhancerAtlas ID | HS197-19401 |
Organism | Homo sapiens |
Tissue/cell | ZR75-30 |
Coordinate | chr7:36696740-36698770 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ALX3 | MA0634.1 | chr7:36698114-36698124 | TCTAATTAAA | + | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09217 | chr7:36694909-36699465 | CD14 | | SE_22399 | chr7:36695091-36699404 | CD8_primiary | | SE_36838 | chr7:36697425-36699813 | HMEC |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH07I036656 | chr7 | 36696172 | 36697520 | | GH07I036657 | chr7 | 36697593 | 36702450 |
|
Enhancer Sequence | GAAACACACA TTTCGACATC AGTTGTTTCT GGTGGTAGGA TTTCAGCTGA CTGTTGTAAG 60
AAGACACCCC AGGGGAGTTT CTGAAACATT GACACCACGT TAGAGCTCAA CCAATCTCTG 120
AGTAGAACAA CCGGGGTGTG AACCCAGTTC TGTTCTTTCC TCGGGAAGTG ACTTTCAGGA 180
AGTCACATAA CTTCTCTAAC CCTCAGTTTC CTCCACTGTA AAAAGGAGTC GAAATGACAC 240
CTCCAACCTA GGCCTGCTTG GGAACAAAAC AAGATCAAGT GTGAGCCTCT ACACCAGCAC 300
TGGGCCCAAA GTGAGTGCCC AGTCAATGTC AGTTACTACT ATTCAGGGGA AGCTCAGAGG 360
CAGAGGAGGG TGAAGCTGTC CATGTGTATA CCCATTGTCC CTCTTTTCTG GGTCATCTGC 420
AGAGATAGAG GCTGGAGAGG GGGACCCGAG GCAGAGGGTG AAGGCCTAGA ACAGCCGTCA 480
GAGGAAAGTG AAGGGGGCTG TCCAGGGAAT CGTCACAGGC TGCCCAGCAG CACTGAATGC 540
TAGCTGGGGT AGAAGGTGGC GGTTCCCACA TGAAATCCTC CAATTCCCTT GCAGCCAGAG 600
GCAGTCGAAA TTTTACAGAG TTAGGAATTG AGAAGGGGGT CAGGGTAGGA AGACAAGGAC 660
ATGAAATTTC AGAAGTAAAC TCTAGAGAGT ATAAAAATAA AGAATGCCAT TTTAAATGGG 720
ACAATTTAAA GTTGAACTTT TTGCGACTAT GTGTAGCTGT GGGTGTAATG TATACATGAC 780
ATTATTATTT AAGGAAATCA CAAAACCTGT GTCACTTGCA TTTCTACACA GAGACCCATT 840
TCTTCCTTGC AATATCAAAC AGAAAATATT ATGATATTAT GATACAATAG TCACACGCTA 900
TTTGAACACA TGAAAAGTTT TTTTTTTAAT TAAAGTTAAC TAACTCTTCT AGGTACCAGT 960
GGAGCCTGCA GCTTCTCAGG TGGAATTAGG GGAAATTTAA TTCGCACTTA GTCAGTGACA 1020
GAGGAAGCTT GAAATATACA CGTTCCTCAG GTAGTTGCAT CTCTTACTTC CTGCTCAAGG 1080
AGACAGGCTG ATGTATTTAA TACTGTCCAT CAGCAAAATC ATGGTCATTG GTTAGGCCAC 1140
AAAGCACTAA AATGAACTTC ATTTTAACAT GAATAAAAAG GAAATTACAA TTAAAATAGA 1200
AACCTATTGT GTTATATCCA GAAAAACTAC AATTCAAGAA AGAAGGCAAA GAATTTTTTT 1260
TCACGGGCAG CTCCTGAAAA TTAATATTCT GTGGCCTAAC TGGATTCAAT ATTATCCTCT 1320
CATCCAGAGT GTGCGGAGGG AATTGTGTCA ACATTTGCAG CCTCCTCTCC GCAATCTAAT 1380
TAAAAGCTAC ACAAAATGAT ATAATGCACA CAGGGTCCTC TGAACAGCTA TCACTGAATA 1440
ATAATGTTAT CAATAATGAT CATTTAGCAG TCATTTCTCT TAACACTTTA AAAACTGTAT 1500
CAGTTATTGT GCTAAGCATT TTTTACATAT TAGCTCACCG ACTTCCCACA ATAAACCACT 1560
GTGGGAGGTA GTTTATCATA ACCCATTTTA TGAGTAAGAG CAATAAGGCT CAGCGTAGGG 1620
TGACCAACTG CCCAGGATTT CCCAAGATGT GGGGCTTTCA GTGCTCATGG CAGGAAAGTC 1680
CTGGGCAAAC TGGCATGAGT TGCTCACTCT GTGAGAGTGA CTTGCTTGAT TTTTAAGTGA 1740
TAGGGATTTA AACCTCTGCG TCTCTTTGAT CAGATTTCCT ACCTACTGGC AGGCCAGCTC 1800
AAAATTACAG TCCACAATGG CTGAACAGCA AAGACATTCT TTCTAGCATG GTAGTATGGA 1860
TCTAGGCCAA AATGCAGGAA TATTATTTCT TGCGGGGTAA TTGAAAATGT CATCTTGCCT 1920
CTCCCTGTCC CCAAAACACT GAGCGAGTAA AAGCTAAGCC TCCCTTTCTA ACATTTCCAA 1980
AAGCCTTGCA TGTCCCTGGA AACAGATGTT CAGAGTGATT ACACACTCAC 2030
|
